LLY

Lilly(Eli) & Co

Oct 17 • 11:21AM ET

795.66

-23.72 -2.89 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF QUAL VHT

Index	S&P 500	P/E	52.76	EPS (ttm)	15.08	Insider Own	10.21%	Shs Outstand	946.83M	Perf Week	-4.54%
Market Cap	753.06B	Forward P/E	26.35	EPS next Y	30.20	Insider Trans	-1.51%	Shs Float	849.83M	Perf Month	4.29%
Enterprise Value	789.50B	PEG	1.27	EPS next Q	6.15	Inst Own	73.40%	Short Float	0.90%	Perf Quarter	4.39%
Income	13.80B	P/S	14.14	EPS this Y	74.36%	Inst Trans	-0.55%	Short Ratio	1.68	Perf Half Y	-5.27%
Sales	53.26B	P/B	41.23	EPS next Y	33.33%	ROA	15.97%	Short Interest	7.69M	Perf YTD	3.07%
Book/sh	19.30	P/C	212.37	EPS next 5Y	41.44%	ROE	86.70%	52W High	935.62 -14.96%	Perf Year	-12.88%
Cash/sh	3.75	P/FCF	154.16	EPS past 3/5Y	24.14% 18.77%	ROIC	26.31%	52W Low	623.78 27.56%	Perf 3Y	145.14%
Dividend Est.	5.86 (0.74%)	EV/EBITDA	32.45	Sales past 3/5Y	16.73% 15.08%	Gross Margin	82.64%	Volatility	2.67% 2.73%	Perf 5Y	415.03%
Dividend TTM	5.80 (0.73%)	EV/Sales	14.82	EPS Y/Y TTM	88.21%	Oper. Margin	42.13%	ATR (14)	22.17	Perf 10Y	823.69%
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	1.00	Sales Y/Y TTM	36.83%	Profit Margin	25.91%	RSI (14)	50.55	Recom	1.58
Dividend Gr. 3/5Y	15.21% 15.05%	Current Ratio	1.28	EPS Q/Q	91.71%	SMA20	-0.26%	Beta	0.41	Target Price	916.54
Payout	44.39%	Debt/Eq	2.18	Sales Q/Q	37.64%	SMA50	5.96%	Rel Volume	1.10	Prev Close	819.38
Employees	47000	LT Debt/Eq	1.87	Earnings	Oct 30 BMO	SMA200	1.18%	Avg Volume	4.59M	Price	795.66
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.70% 5.80%	Trades		Volume	1,622,490	Change	-2.89%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525

Show Previous Ratings

Today 11:08AM	Here's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly Stocks (Investopedia)
10:58AM	Pharma Stocks Fall After Trump Says Ozempic Could Be Much Cheaper (The Wall Street Journal)
10:50AM	Stock Market Today: Dow Rebounds After Bank Scare; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
10:39AM	Novo, Lilly Fall as Trump Touts Much Lower Ozempic Price (Bloomberg)
10:16AM	Eli Lilly, Novo Nordisk Stocks Drop. Trump Targets Ozempic, Fat Loss Drug Prices. (Barrons.com)
10:01AM	Loading…
10:01AM	Trump says Ozempic will get much cheaper. Novo Nordisk and Eli Lilly shares tumble (Quartz)
09:53AM	These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More (Barrons.com)
09:52AM	Trump says Ozempic will get cheaper. Novo Nordisk, Eli Lilly stock slump (Quartz)
09:43AM	Stock Market Today: Dow Up Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
09:36AM	Drugmakers slide on Trump comments, EssilorLuxottica's Meta glasses (Yahoo Finance Video)
09:30AM	Pre-Q3 Earnings: Is Viking Therapeutics Stock a Portfolio Must-Have? (Zacks)
09:23AM	Eli Lilly, Novo Nordisk Tumbles After Trump Says Weight-Loss Drugs Are 'Too Expensive' (GuruFocus.com)
09:05AM	Eli Lilly Sets Ambitious Sustainability Goals Despite Headwinds (Investor's Business Daily)
08:48AM	Stock Market Today: Dow Edges Up Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
08:35AM	5 Things to Know Before the Stock Market Opens (Investopedia)
08:12AM	Loading…
08:12AM	Stock Market Today: Dow Falls Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
08:05AM	Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug (Investor's Business Daily)
08:00AM	Lilly's Verzenio (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment (PR Newswire)
07:35AM	Novo Nordisk falls on Trump threat to lower Ozempic prices and other morning movers (MarketWatch)
07:18AM	Eli Lilly, Novo Nordisk Stocks Drop After Trump's Ozempic Price Comment. What to Know. (Barrons.com)
06:24AM	Lilly, Novo Slide as Trump Touts 'Much Lower' Ozempic Price (Bloomberg)
06:22AM	The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics (Zacks)
05:56AM	These Stocks Are Moving the Most Today: Zions Bancorp, Oracle, Novo Nordisk, Eli Lilly, Interactive Brokers, CSX, American Express, and More (Barrons.com)
04:15AM	Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? (Motley Fool)
Oct-16-25 05:22PM	Novo Nordisk, Eli Lilly slide after Trump comments on weight loss drug pricing (Investing.com)
01:55PM	LLY's Oral GLP-1 Pill Scores Another Pair of Diabetes Wins (Zacks)
11:10AM	NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio (Zacks)
10:00AM	Lilly confirms date and conference call for third-quarter 2025 financial results announcement (PR Newswire)
09:48AM	2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades (Motley Fool)
09:31AM	How Will Mounjaro and Zepbound Sales Aid Lilly's Upcoming Q3 Results? (Zacks)
07:51AM	Loading…
07:51AM	Here's What to Expect From Eli Lillys Next Earnings Report (Barchart)
07:45AM	Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly? (Motley Fool)
07:01AM	Eli Lillys oral GLP-1RA gains fourth Phase III type 2 diabetes win (Clinical Trials Arena)
01:34AM	Erste Group Upgrades Eli Lilly (LLY) to Buy Following Strong First-Half Results (Insider Monkey)
Oct-15-25 05:45PM	Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know (Zacks)
04:15PM	Novo Nordisk's Akero Therapeutics Buy Targets Eli Lilly's Lead (MarketBeat)
07:03AM	Lilly, battling skepticism, reinforces GLP-1 pills case with new study data (BioPharma Dive)
06:45AM	Lilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes (PR Newswire)
03:30AM	New to Investing? These Are 3 Solid Blue Chip Stocks You Can Build Your Portfolio Around (Motley Fool)
02:23AM	Inside Novo Nordisk's 'Club 5,000' as Danish staff cuts gain pace (Reuters Videos)
Oct-14-25 08:05PM	1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today (Motley Fool)
02:09PM	3 Healthcare Companies Insiders Are Buying (MarketBeat)
12:02PM	Kailera nets $600m to power Phase III launch of obesity drug (Pharmaceutical Technology)
11:09AM	Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie? (Zacks)
07:45AM	Kailera nets $600M more to advance Zepbound-like obesity drug (BioPharma Dive)
04:38AM	The Zacks Analyst Blog Highlights Apple, Eli Lilly and Visa (Zacks)
Oct-13-25 04:15PM	Top Stock Reports for Apple, Eli Lilly & Visa (Zacks)
01:40PM	AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve (Zacks)
10:57AM	New US biotech hubs showing potential amid onshoring request (Pharmaceutical Technology)
09:28AM	Eli Lilly Omvoh Demonstrates Sustained Long-Term Benefits in Ulcerative Colitis Up to Four Years (Insider Monkey)
06:45AM	Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting (PR Newswire)
06:10AM	Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? (Motley Fool)
Oct-11-25 07:00AM	MarketBeat Week in Review - 10/06 - 10/10 (MarketBeat)
Oct-10-25 09:54AM	Can Novo Nordisk's Aggressive Deal-Making Offset Semaglutide Reliance? (Zacks)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
06:45AM	2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now (Motley Fool)
06:30AM	Novo Nordisk Seeks to Expand Liver Disease Treatments in $5.2B Deal for Bay Area Biotech (The Daily Upside)
05:32AM	Pharma R&D set to endure despite rising MFN costs (Clinical Trials Arena)
Oct-09-25 05:45PM	Eli Lilly (LLY) Gains As Market Dips: What You Should Know (Zacks)
03:26PM	A Major Eli Lilly Shareholder Has Sold Stock Nearly Every Day in October. Here's Who It Is. (Barrons.com)
11:17AM	Novo Nordisk Is Buying Akero Therapeutics. Its More Good News for Biotech Stocks. (Barrons.com)
11:00AM	Is Novo Nordisk Stock a Sell Despite its 10% Price Rally in a Month? (Zacks)
10:14AM	AbbVie vs. Eli Lilly: Which Large Drugmaker Has the Edge in 2025? (Zacks)
10:08AM	Novo Nordisk buys MASH specialist Akero for up to $5.2bn (Pharmaceutical Technology)
08:03AM	5 Healthcare Plays Powering the Sector's Big Comeback (MarketBeat)
07:30AM	Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market (Motley Fool)
Oct-08-25 04:47PM	Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run (Investor's Business Daily)
03:55PM	Tariff turbulence deepens uncertainty across US supply chains (FreightWaves)
10:56AM	Can BMYs Neuroscience Portfolio Help to Diversify Its Business? (Zacks)
10:43AM	Ex-FDA chief Peter Marks joins Eli Lillys infectious disease unit (Pharmaceutical Technology)
10:02AM	Guggenheim Reaffirms Its Buy Rating on Eli Lilly & Company (LLY) with Price Target of $875 (Insider Monkey)
06:31AM	These 2 AI Stocks Could Surpass Oracle in Market Cap by 2030 (Motley Fool)
Oct-07-25 06:01PM	Top Stock Picks for Week of October 6, 2025 (Zacks)
05:04PM	Former Top FDA Official, Forced Out by Kennedy, Lands at Eli Lilly (Barrons.com)
12:20PM	Peter Marks, former top FDA vaccine official, joins Eli Lilly (BioPharma Dive)
09:33AM	Where Will LLY Be in 5 Years? (Motley Fool)
09:00AM	Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
06:45AM	Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis (PR Newswire)
06:05AM	Eli Lilly to invest more than $1B in India, Reuters reports (TipRanks)
06:00AM	Hiltzik: There's much less than meets the eye in Trump's 'historic' drug price deal with Pfizer (LA Times)
05:53AM	Novo Nordisk cuts hit production line jobs at key US plant, posts show (Reuters Videos)
04:50AM	Eli Lilly plans major $1bn expansion in Telangana, India (Investment Monitor)
Oct-06-25 07:34PM	Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal (MarketBeat)
05:21PM	Eli Lilly to Invest Over $1 Billion in India to Expand Manufacturing Network (GuruFocus.com)
02:57PM	Eli Lilly's $1 Billion India Gamble Signals Pharma's Next Global Power Shift (GuruFocus.com)
02:21PM	Trump's Drug Price Cuts: Boom or Bust for These 3 Pharma Giants (MarketBeat)
01:57PM	Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know (Zacks)
10:11AM	AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week? (Zacks)
09:56AM	Eli Lilly: Beyond Weight Loss (Motley Fool)
09:03AM	Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk (Zacks)
07:35AM	Trogenix lands $95m Series A, backed by Eli Lilly, for brain cancer therapy (Pharmaceutical Technology)
06:30AM	Eli Lilly to invest over $1 billion in India in global expansion (Reuters Videos)
Oct-04-25 05:01PM	Jim Cramer Highlights Eli Lilly's Drug Potential Beyond Diabetes and Obesity (Insider Monkey)
02:30AM	Novo Nordisk Is Ready for Another Round of the Weight-Loss-Drug Wars (Barrons.com)
Oct-03-25 05:45PM	Eli Lilly (LLY) Laps the Stock Market: Here's Why (Zacks)
04:55PM	5 Large Cap Drug Stocks: Values or Traps? (Zacks)
11:48AM	Palantir, AI bubble comments, pharma stocks: Trending Tickers (Yahoo Finance Video)
10:47AM	Why Shares of Eli Lilly Soared This Week (Motley Fool)
10:06AM	MRK Stock Up Nearly 14% So Far This Week: What's Driving It? (Zacks)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience